ADHD treatment with once-daily OROS methylphenidate: Interim 12-month results from a long-term open-label study Article

Wilens, T, Pelham, W, Stein, M et al. (2003). ADHD treatment with once-daily OROS methylphenidate: Interim 12-month results from a long-term open-label study . JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 42(4), 424-433. 10.1097/01.CHI.0000046814.95464.7D

cited authors

  • Wilens, T; Pelham, W; Stein, M; Conners, CK; Abikoff, H; Atkins, M; August, G; Greenhill, L; McBurnett, K; Palumbo, D; Swanson, J; Wolraich, M

sustainable development goals

publication date

  • April 1, 2003

keywords

  • A-DAY
  • ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
  • BOYS
  • CHILDREN
  • DEFICIT HYPERACTIVITY DISORDER
  • EFFICACY
  • GROWTH
  • Life Sciences & Biomedicine
  • Pediatrics
  • Psychiatry
  • Psychology
  • Psychology, Developmental
  • SLEEP
  • STIMULANT TREATMENT
  • Science & Technology
  • Social Sciences
  • attention-deficit/hyperactivity disorder
  • long-term study
  • methylphenidate
  • safety

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 424

end page

  • 433

volume

  • 42

issue

  • 4